DD220780A5 - Verfahren zur herstellung von 5-subst.-(1,2,4) triazolo (1,5-c) pryimidin-2-aminen - Google Patents
Verfahren zur herstellung von 5-subst.-(1,2,4) triazolo (1,5-c) pryimidin-2-aminen Download PDFInfo
- Publication number
- DD220780A5 DD220780A5 DD84265730A DD26573084A DD220780A5 DD 220780 A5 DD220780 A5 DD 220780A5 DD 84265730 A DD84265730 A DD 84265730A DD 26573084 A DD26573084 A DD 26573084A DD 220780 A5 DD220780 A5 DD 220780A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- triazolo
- pyrimidine
- hours
- amine
- pyrimidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51825083A | 1983-07-28 | 1983-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD220780A5 true DD220780A5 (de) | 1985-04-10 |
Family
ID=24063190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD84265730A DD220780A5 (de) | 1983-07-28 | 1984-07-27 | Verfahren zur herstellung von 5-subst.-(1,2,4) triazolo (1,5-c) pryimidin-2-aminen |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0132851B1 (es) |
| JP (1) | JPS6056983A (es) |
| KR (1) | KR900004000B1 (es) |
| AT (1) | ATE46907T1 (es) |
| AU (1) | AU570989B2 (es) |
| CA (1) | CA1224785A (es) |
| DD (1) | DD220780A5 (es) |
| DE (1) | DE3427823A1 (es) |
| DK (1) | DK365284A (es) |
| ES (1) | ES534681A0 (es) |
| GR (1) | GR82440B (es) |
| HK (1) | HK4391A (es) |
| HU (1) | HU190936B (es) |
| IE (1) | IE57939B1 (es) |
| IL (1) | IL72529A (es) |
| NZ (1) | NZ208996A (es) |
| PL (1) | PL248968A1 (es) |
| ZA (1) | ZA845842B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0244948A3 (en) * | 1986-04-30 | 1989-03-15 | Schering Agrochemicals Limited | Triazolopyrimidine herbicides |
| ATE257156T1 (de) | 1997-03-24 | 2004-01-15 | Kyowa Hakko Kogyo Kk | (1,2,4)triazolo(1,5-c)pyrimidin-derivate |
| BR9914040A (pt) | 1998-09-22 | 2002-01-15 | Kyowa Hakko Kogyo Kk | Derivados de [1,2,4]triazolo[1,5-c]pirimidina e seu uso, medicamento, antagonista, agente para prevenir ou tratar doenças, bem como processo para prevenção ou tratamento de distúrbios |
| GB0719803D0 (en) | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| TWI462920B (zh) | 2009-06-26 | 2014-12-01 | 葛萊伯格有限公司 | 用於治療退化性及發炎疾病之新穎化合物 |
| MX2012013648A (es) * | 2010-05-25 | 2013-02-11 | Dow Agrosciences Llc | Proceso para la preparacion de 8-alcoxi [1, 2, 4] triazol [1, 5-c]pirimidin-2-aminas substituidas-5. |
| KR102629882B1 (ko) * | 2023-05-10 | 2024-01-29 | 김황래 | 조적수평장치 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3045015A (en) * | 1958-10-03 | 1962-07-17 | Ici Ltd | Triazolo-[2, 3-c]-pyrimidines |
| US3053844A (en) * | 1959-04-13 | 1962-09-11 | Ici Ltd | Mono-acyl derivatives of s-triazolo [2, 3-c] pyrimidines |
| US3046276A (en) * | 1959-06-15 | 1962-07-24 | Ici Ltd | S-triazolo-[2, 3-c] pyrimidine derivatives |
| US4269980A (en) * | 1979-12-17 | 1981-05-26 | American Cyanamid Company | (Substituted-phenyl)-1,2,4-triazolo[4,3-c]pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-c]pyrimidines |
-
1984
- 1984-07-24 NZ NZ208996A patent/NZ208996A/xx unknown
- 1984-07-26 DK DK365284A patent/DK365284A/da not_active Application Discontinuation
- 1984-07-27 IE IE1943/84A patent/IE57939B1/en not_active IP Right Cessation
- 1984-07-27 DD DD84265730A patent/DD220780A5/de unknown
- 1984-07-27 HU HU842896A patent/HU190936B/hu not_active IP Right Cessation
- 1984-07-27 JP JP59157117A patent/JPS6056983A/ja active Granted
- 1984-07-27 DE DE19843427823 patent/DE3427823A1/de not_active Ceased
- 1984-07-27 AT AT84108922T patent/ATE46907T1/de not_active IP Right Cessation
- 1984-07-27 AU AU31240/84A patent/AU570989B2/en not_active Ceased
- 1984-07-27 PL PL24896884A patent/PL248968A1/xx unknown
- 1984-07-27 KR KR1019840004482A patent/KR900004000B1/ko not_active IP Right Cessation
- 1984-07-27 CA CA000459938A patent/CA1224785A/en not_active Expired
- 1984-07-27 ZA ZA845842A patent/ZA845842B/xx unknown
- 1984-07-27 IL IL72529A patent/IL72529A/xx unknown
- 1984-07-27 EP EP84108922A patent/EP0132851B1/en not_active Expired
- 1984-07-27 ES ES534681A patent/ES534681A0/es active Granted
- 1984-07-30 GR GR75446A patent/GR82440B/el unknown
-
1991
- 1991-01-10 HK HK43/91A patent/HK4391A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA845842B (en) | 1985-03-27 |
| IL72529A0 (en) | 1984-11-30 |
| JPS6056983A (ja) | 1985-04-02 |
| JPH0447671B2 (es) | 1992-08-04 |
| AU3124084A (en) | 1985-01-31 |
| IL72529A (en) | 1988-05-31 |
| CA1224785A (en) | 1987-07-28 |
| DE3427823A1 (de) | 1985-02-07 |
| EP0132851B1 (en) | 1989-10-04 |
| HK4391A (en) | 1991-01-18 |
| PL248968A1 (en) | 1985-10-22 |
| IE841943L (en) | 1985-01-25 |
| IE57939B1 (en) | 1993-05-19 |
| DK365284D0 (da) | 1984-07-26 |
| ATE46907T1 (de) | 1989-10-15 |
| ES8505684A1 (es) | 1985-06-16 |
| KR900004000B1 (ko) | 1990-06-07 |
| GR82440B (es) | 1984-12-13 |
| AU570989B2 (en) | 1988-03-31 |
| EP0132851A1 (en) | 1985-02-13 |
| NZ208996A (en) | 1989-08-29 |
| DK365284A (da) | 1985-01-29 |
| HU190936B (en) | 1986-12-28 |
| HUT34752A (en) | 1985-04-28 |
| KR850001215A (ko) | 1985-03-16 |
| ES534681A0 (es) | 1985-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60110749T2 (de) | Pyridinderivative als angiogenese- und/oder vegf-rezeptor-tyrosinkinase-inhibitoren | |
| DE602005004287T2 (de) | Pyrrazolopyrimidinderivate | |
| DE60104671T2 (de) | Imidazopyrimidin-derivate und triazolopyrimidin-derivate | |
| DE69530989T2 (de) | Neue pyrimidinderivate und verfahren zu ihrer herstellung | |
| DE69925970T2 (de) | Pyrazolopyrimidinone cGMP PDE5 Inhibitoren zur Behandlung der sexuellen Dysfunktion | |
| DE602004010848T2 (de) | Derivate von 1-piperazin- und 1-homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms | |
| US4886807A (en) | Novel pyrimidopyrimidine derivative, process for producing it and pharmaceutical composition | |
| EP0877744B1 (de) | Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung | |
| CH656383A5 (de) | 2-(4-(4-(4,4-dialkyl-2,6-piperidindion-1-yl)-butyl)-1-piperazinyl)pyrimidine. | |
| DE2237765A1 (de) | Neue aminoderivate von pyrazolo (3,4-b)pyridin-5-carbonsaeuren mit deren estern und salzen, verfahren zu ihrer herstellung und ihre verwendung | |
| DE60209721T2 (de) | Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore | |
| DE2149249A1 (de) | 6-Arylpyrimidine | |
| DD150466A5 (de) | Verfahren zur herstellung substituierter 3-alkyl-6-phenyl-1,2,4-triazolo[4,3-a]pyridine | |
| DD158776A5 (de) | Verfahren zur herstellung von di-oder triesubstituiertenxanthinen | |
| DE60004671T2 (de) | Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung | |
| US4236004A (en) | 2-Alkylsulphonyl-7,8-dihydro-5-hydroxy-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives | |
| DE2849537A1 (de) | Substituierte 5-(2-imidazolin-2-yl)- aminopyrimidine und verfahren zu deren herstellung | |
| DE1946315A1 (de) | Neue heterocyclische Verbindungen | |
| DE2333603A1 (de) | Neue derivate von dipyrazolopyridinen und ihre salze | |
| DD220780A5 (de) | Verfahren zur herstellung von 5-subst.-(1,2,4) triazolo (1,5-c) pryimidin-2-aminen | |
| DE602004004259T2 (de) | (6-(PHENOXY)-PYRIDOi3,4-DöPYRIMIDIN-2-YL)-AMIN DERIVATE ALS P38 KINASE INHIBITOREN ZUR BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN WIE RHEUMATOIDER ARTHRITIS | |
| DE2264374C3 (de) | 4-Hydroxy-5-phenoxy-pyrimidine, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat | |
| DE2502119A1 (de) | Modifizierte antibiotica | |
| DE3814057A1 (de) | 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| US4301281A (en) | 7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]-pyrimidine-6-carboxylic acid amides |